This company is the result of Nationwide Children's reviving gene therapy in the U.S.
It ’s the stuff of science fiction – replacing defective genes in the human body with new ones that will stop a debilitating disease. But it seems to becoming reality at Michael Triplett’s new Columbus gene therapy company, which is having success controlling a rare muscular dystrophy disease tha t cripples its patients.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Source Type: news
More News: Children | Gene Therapy | Genetics | Health Management | Muscular Dystrophy | Reflex Sympathetic Dystrophy | Science